• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
How Do I Confirm that a New Mutation is Pathogenic?我如何确认一个新的突变是致病性的?
Mov Disord Clin Pract. 2018 Mar 23;5(2):229. doi: 10.1002/mdc3.12600. eCollection 2018 Mar-Apr.
2
The trap of genetic tag: The importance of pathogenicity prediction tools in the correct interpretation of variants of uncertain significance in the era of high-throughput genome sequencing.基因标签的陷阱:在高通量基因组测序时代,致病性预测工具对正确解读意义未明变异的重要性。
Clin Case Rep. 2023 May 3;11(5):e7054. doi: 10.1002/ccr3.7054. eCollection 2023 May.
3
4
Targeted 46-gene and clinical exome sequencing for mutations causing cardiomyopathies.针对导致心肌病的突变进行的46基因和临床外显子组测序。
Mol Cell Probes. 2015 Oct;29(5):308-14. doi: 10.1016/j.mcp.2015.05.004. Epub 2015 May 12.
5
How Do I Report Genes in a Paper?我该如何在论文中报告基因?
Mov Disord Clin Pract. 2024 May;11(5):594-597. doi: 10.1002/mdc3.13984. Epub 2024 Mar 12.
6
Pathogenicity discrimination and genetic test reference for CRX variants based on genotype-phenotype analysis.基于基因型-表型分析的 CRX 变异体的致病性判别和遗传检测参考。
Exp Eye Res. 2019 Dec;189:107846. doi: 10.1016/j.exer.2019.107846. Epub 2019 Oct 15.
7
Caution in interpretation of disease causality for heterozygous loss-of-function variants in the MYH8 gene associated with autosomal dominant disorder.在解释与常染色体显性疾病相关的MYH8基因杂合功能丧失变异的疾病因果关系时需谨慎。
Eur J Med Genet. 2017 Jun;60(6):312-316. doi: 10.1016/j.ejmg.2017.03.012. Epub 2017 Apr 2.
8
Pathogenic variant burden in the ExAC database: an empirical approach to evaluating population data for clinical variant interpretation.ExAC数据库中的致病变异负担:一种评估群体数据用于临床变异解读的实证方法。
Genome Med. 2017 Feb 6;9(1):13. doi: 10.1186/s13073-017-0403-7.
9
Actionable Pharmacogenetic Variation in the Slovenian Genomic Database.斯洛文尼亚基因组数据库中的可操作药物遗传学变异
Front Pharmacol. 2019 Mar 14;10:240. doi: 10.3389/fphar.2019.00240. eCollection 2019.
10
Bioinformatics Tools and Databases to Assess the Pathogenicity of Mitochondrial DNA Variants in the Field of Next Generation Sequencing.用于评估下一代测序领域中线粒体DNA变异致病性的生物信息学工具和数据库
Front Genet. 2018 Dec 11;9:632. doi: 10.3389/fgene.2018.00632. eCollection 2018.

引用本文的文献

1
MDSGene: Closing Data Gaps in Genotype-Phenotype Correlations of Monogenic Parkinson's Disease.MDSGene:填补单基因帕金森病基因型-表型相关性中的数据空白。
J Parkinsons Dis. 2018;8(s1):S25-S30. doi: 10.3233/JPD-181505.

我如何确认一个新的突变是致病性的?

How Do I Confirm that a New Mutation is Pathogenic?

作者信息

Trinh Joanne, Tadic Vera, Klein Christine

机构信息

Institute of Neurogenetics Luebeck Germany.

出版信息

Mov Disord Clin Pract. 2018 Mar 23;5(2):229. doi: 10.1002/mdc3.12600. eCollection 2018 Mar-Apr.

DOI:10.1002/mdc3.12600
PMID:30868102
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6407058/
Abstract

Whole exome, genome sequencing, and other massive parallel next generation sequencing technologies have increasingly been used as a clinical diagnostic tool in recent years. Although sequencing technologies are becoming more affordable and widely used, the interpretation of variants from these large datasets at the level of personalized medicine is not clear-cut. For example, many rare missense variants identified may or may not have an impact on gene function and can be problematic to interpret in a clinical setting. Thus, there is a need for a systematic approach to applying, reporting, and evaluating variants identified. One important aspect is to determine the pathogenicity of a variant based on scientific literature. This tutorial is meant to serve as an introduction to scoring pathogenicity of variants, enabling movement disorder specialists to familiarize themselves with online tools to independently determine pathogenicity of variants identified in genetic testing reports.

摘要

近年来,全外显子测序、基因组测序以及其他大规模平行下一代测序技术越来越多地被用作临床诊断工具。尽管测序技术的成本越来越低且应用越来越广泛,但在个性化医疗层面,对这些大型数据集中变异的解读并不明确。例如,许多鉴定出的罕见错义变异可能会也可能不会对基因功能产生影响,在临床环境中进行解读可能会有问题。因此,需要一种系统的方法来应用、报告和评估鉴定出的变异。一个重要方面是根据科学文献确定变异的致病性。本教程旨在作为变异致病性评分的入门介绍,使运动障碍专家能够熟悉在线工具,从而独立确定基因检测报告中鉴定出的变异的致病性。